Dr. Lawrence Daniel Koutcher, MD

Dr. Koutcher practices at Newyork-presbyterian Medical Group/westchester in Yorktown Heights, New York.

Dr. Koutcher's NPI, 1316141773, was assigned on June 12, 2007. Dr. Koutcher graduated from Weill Cornell Medicine in 2005. Dr. Koutcher's New York license number on file is 240791-1.

Dr. Koutcher's primary practice is Newyork-presbyterian Medical Group/westchester, at 2649 Strang Blvd Suite 304 Suite 304, Yorktown Heights, NY 10598-2938. The practice phone is (646) 697-5663.

Dr. Koutcher's primary practice is Newyork-presbyterian Medical Group/westchester in Yorktown Heights, New York. Dr. Koutcher is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is NewYork-Presbyterian Medical Group Westchester. Dmand AI also links Dr. Koutcher to 1 more hospital, 2 group practices and clinics, 2 medical groups and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Koutcher practices, 6 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Koutcher's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Koutcher is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Koutcher's licenses on file in 2 states: New York and New Jersey.

Dmand AI lists bladder cancer radiation, brain cancer radiation, breast cancer radiation, cancer radiation-upper GI, colorectal cancer radiation, head & neck cancer radiation, lung cancer radiation and pancreatic cancer radiation among the conditions Dr. Koutcher treats.

CMS data shows 3,194 Medicare services from Dr. Koutcher across 19 procedure codes in 2024, for 304 Medicare patients. Medicare paid $267,184 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 304 Medicare patients who saw Dr. Koutcher in 2024. The largest group is 75 to 84, with 135 patients. 75% of them have cancer, and 75% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Koutcher's median patient age at 75, with 22% women.

In 2024, Dr. Koutcher wrote 135 Medicare Part D claims for 67 patients. 83% of them were for generic drugs. CMS names the drug for 115 of them, across 4 drugs with 11 or more claims each, at $16,444 in total drug cost. In 2023, CMS named 55 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Koutcher for performance year 2024, reported through an alternative payment model (APM). Dr. Koutcher accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Koutcher as offering telehealth.

Dmand AI links 12 papers to Dr. Koutcher, published from 2010 to 2023. 2010 was the busiest year, with 3. The most frequent topics are Radiotherapy, Intensity-Modulated, Cetuximab and Cisplatin. Dr. Koutcher has published most often in Int J Radiat Oncol Biol Phys. Dr. Koutcher's most frequent co-authors are Nancy Lee, MD, Suzanne L. Wolden, MD and Richard J. Wong, MD.

CMS Open Payments shows 3 general payments to Dr. Koutcher from 3 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $29.

Dmand AI lists 1 award for Dr. Koutcher, most recently CMS Stage 1 EHR in 2013.

Dr. Koutcher graduated from Weill Cornell Medicine in 2005.

Dr. Koutcher is in network with 20 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.